Results 111 to 120 of about 137,343 (204)

Early-Onset Vogt-Koyanagi-Harada-Like Syndrome After Combined Ipilimumab and Nivolumab for Metastatic Melanoma: A Case Report. [PDF]

Cureus
Etheve F, Hainaut E, Boutin D, Riviere R.   +3 more
europepmc   +1 more source

Tislelizumab-induced Vogt-Koyanagi-Harada-like uveitis: a case report. [PDF]

BMC Ophthalmol
Zhou Y, Lei X, Ma W.
europepmc   +1 more source

Late-onset optic disc swelling-type Vogt-Koyanagi-Harada disease: diagnostic value of longitudinal multimodal imaging. [PDF]

J Ophthalmic Inflamm Infect
Goncharova T, Garcia-Hidalgo S, Sole OB, Pairó-Salvador A, Bertolani Y, Kirkegaard-Biosca E, Distefano L.   +6 more
europepmc   +1 more source

Adalimumab Reprograms M1 Macrophages to Attenuate Th1/Th17 Responses in Behçet's Uveitis and Vogt-Koyanagi-Harada Syndrome. [PDF]

Invest Ophthalmol Vis Sci
Zhu Y, Yu Q, Ma Y, Huang L, Ding J, Gao X, Ma L, Zhang D, Zhang B, Wang S, Chu WK, Su G, Yang P.   +12 more
europepmc   +1 more source

Surgical drainage of severe Vogt-Koyanagi-Harada-like syndrome secondary to immunotherapy. [PDF]

Am J Ophthalmol Case Rep
Villain P, Naux G, Bellot L.
europepmc   +1 more source

Vogt-Koyanagi-Harada Disease with Oral Manifestations: A Rare Case Report. [PDF]

Contemp Clin Dent
Rani N, Yadav S, Kaur A, Kaur CK, Kumar U.   +4 more
europepmc   +1 more source

Case Report: Vogt-Koyanagi-Harada-like uveitis associated with combined dabrafenib/trametinib and cadonilimab therapy for cutaneous melanoma. [PDF]

Front Med (Lausanne)
Wang H, Zhang R, Zhou L, Liang Q, Ma H, Nie X, Su G.   +6 more
europepmc   +1 more source

Segmental choroidal vascularity in Acute Vogt-Koyanagi-Harada disease. [PDF]

Int J Retina Vitreous
Jacob N, Sahoo NK, Chhablani J, Mohammed AR, Vupparaboina KK, G J, Hansraj S, Tyagi M.   +7 more
europepmc   +1 more source

Vogt-Koyanagi-Harada Syndrome: Clinical Features, Immunogenetic Predisposition and PD-1 Inhibitor-Induced Forms-A Comprehensive Review. [PDF]

J Clin Med
Orłowska SM, Bednarczyk Ł, Morshed K, Tyniec M, Olczyk P.   +4 more
europepmc   +1 more source

Novel application for the JAK inhibitor baricitinib in the treatment of Vogt-Koyanagi-Harada disease: a prospective cohort study. [PDF]

Front Immunol
Luo H, Chen B, Zhang X.
europepmc   +1 more source